Published

Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The Australian and New Zealand journal of psychiatry
Date: 2026-02-01
Source: PubMed
DOI: 10.1177/00048674251398677
PubMed: 41405025

Authors

Dutton M Schwenn P Mitchell J Hoffmann P Bailey NW Fitzgerald PB Lagopoulos J Can AT

Watch author

Derived topics and classifications

psilocybin Depression Mechanism of Action Treatment-Resistant Depression Safety Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.2026-02-01

Related papers

The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidenceZenodo (CERN European Organization for Nuclear Research) · 2026-01-26 Psychedelics: Future Therapeutics in Major Depression?Advances in experimental medicine and biology · 2026-01-01 Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.Frontiers in neuroscience · 2026-01-01 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Psilocybin: the magic medicine for depression?BJPsych open · 2021-06-18 Psilocybin: the magic medicine for depression?BJPsych Open · 2021-06-01 Should addiction researchers be interested in psychedelic science?Drug and Alcohol Review · 2017-04-10